SYNCRELITY
Live / Allowed — Approved for publication (as of 30 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Jan 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99609094
- Mark type
- Stylized text
- Filed
- 22 Jan 2026
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders
Owner
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 30 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Mar 2026 — ASSIGNED TO EXAMINER
- 22 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 22 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Jan 2026 — NEW APPLICATION ENTERED